Prevalence for ITP is 3.3 per 100,000 people. In
Post# of 148185
(Total Views: 487)
Posted On: 08/21/2022 3:49:09 PM
Prevalence for ITP is 3.3 per 100,000 people. In the US, there are 329,500,000 people. That med the patient is on is likely Prednisone. Cortisone is a steroid with significant side effects. However, with Leronlimab, there are no side effects.
Now if Leronlimab were prescribed for it 100%, that would turn out to be 10,874 patients with an injection weekly, or every 2 or 3 or 4 weeks depending on severity of the disease and how well Leronlimab worked.
A normal platelet count is between 150,000 and 400,000. Provided it got patients platelet levels greater than 150,000, leronlimab would be considered effective.
So although it may be considered "Rare", even this rare disease could turn out to be very profitable and worth pursuing if it proves effective in early trials.
Now if Leronlimab were prescribed for it 100%, that would turn out to be 10,874 patients with an injection weekly, or every 2 or 3 or 4 weeks depending on severity of the disease and how well Leronlimab worked.
A normal platelet count is between 150,000 and 400,000. Provided it got patients platelet levels greater than 150,000, leronlimab would be considered effective.
So although it may be considered "Rare", even this rare disease could turn out to be very profitable and worth pursuing if it proves effective in early trials.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼